EcoDrugPlus

Membrane Metalloendopeptidase

Ensembl ID : ENSELUG00000018554
Gene Symbol: MME
4 Cross references
234 Possible Orthologues:

Metabotropic Glutamate Receptor 2

Ensembl ID : ENSELUG00000002750
Gene Symbol: LOC105016916
3 Cross references
210 Possible Orthologues:

Metabotropic Glutamate Receptor 3

Ensembl ID : ENSELUG00000020158
Gene Symbol: LOC105018424
3 Cross references
212 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSELUG00000003080
Gene Symbol: METAP2
4 Cross references
229 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSELUG00000023431
Gene Symbol: LOC105012809
3 Cross references
198 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSELUG00000011849
Gene Symbol: MAPK1
3 Cross references
214 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSELUG00000030357
Gene Symbol: MAPK10
3 Cross references
221 Possible Orthologues:

Mitogen-Activated Protein Kinase 11

Ensembl ID : ENSELUG00000004394
Gene Symbol: LOC105020226
3 Cross references
201 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSELUG00000019598
Gene Symbol: MAPK14
1 Cross references
182 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSELUG00000011666
Gene Symbol: MAPK14
3 Cross references
187 Possible Orthologues:

Mitogen-Activated Protein Kinase 8

Ensembl ID : ENSELUG00000006089
Gene Symbol: LOC105006595
3 Cross references
223 Possible Orthologues:

Mitogen-Activated Protein Kinase 8

Ensembl ID : ENSELUG00000010249
Gene Symbol: LOC105027233
3 Cross references
222 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).